MESOBLAST LIMITED - Announcements

6.53%

$2.12

Market Cap $2.713B

Healthcare Biotechnology

Mesoblast Limited is an Australia-based company, which is engaged in developing... Mesoblast Limited is an Australia-based company, which is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. It has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates. It is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, and biologic-resistant inflammatory bowel disease. Rexlemestrocel-L is being developed for advanced chronic heart failure (REVASCOR) and chronic low back pain (MPC-06-ID). Two products have been commercialized in Japan and Europe by the Company's licensees. It has established commercial partnerships in Europe and China for certain Phase III assets.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. LATEST: Race Oncology Accelerates Game-Changing Cancer Drug.

Announcements

Filter Results

All Price Sensitive Only

MSB	Proposed issue of securities - MSB		04/09/25	16.86KB	Share
MSB	Mesoblast Option to Issue up to US$50m Convertible Notes	PRICE SENSITIVE	04/09/25	158.61KB	Share
MSB	Becoming a substantial holder		29/08/25	469.8KB	Share
MSB	MSB Annual Financial Results and Operational Update	PRICE SENSITIVE	29/08/25	411.86KB	Share
MSB	Annual Financial Results Presentation	PRICE SENSITIVE	29/08/25	2.08MB	Share
MSB	Preliminary Final Report including Appendix 4E	PRICE SENSITIVE	29/08/25	2.69MB	Share
MSB	Mesoblast 2025 Full Year Financial Results Webcast		27/08/25	190.38KB	Share
MSB	Ceasing to be a substantial holder		25/08/25	584.98KB	Share
MSB	Becoming a substantial holder		29/07/25	806.3KB	Share
MSB	Ceasing to be a substantial holder		25/07/25	559.18KB	Share
MSB	Ceasing to be a substantial holder		25/07/25	1.58MB	Share
MSB	Becoming a substantial holder		23/07/25	2.04MB	Share
MSB	Ceasing to be a substantial holder		21/07/25	1.51MB	Share
MSB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	18/07/25	455.43KB	Share
MSB	Becoming a substantial holder		18/07/25	2.32MB	Share
MSB	Notification of cessation of securities - MSB		14/07/25	12.81KB	Share
MSB	Notification regarding unquoted securities - MSB		14/07/25	14.47KB	Share
MSB	Application for quotation of securities - MSB		14/07/25	17.77KB	Share
MSB	Notification regarding unquoted securities - MSB		14/07/25	15.93KB	Share
MSB	Ceasing to be a substantial holder		08/07/25	1.29MB	Share
MSB	Becoming a substantial holder		07/07/25	2.06MB	Share
MSB	Mesoblast and FDA Align on Key Items for Revascor BLA		01/07/25	184.33KB	Share
MSB	Ceasing to be a substantial holder		26/06/25	1.16MB	Share
MSB	Ceasing to be a substantial holder		18/06/25	243.32KB	Share
MSB	Becoming a substantial holder		17/06/25	1.88MB	Share
MSB	Ceasing to be a substantial holder		16/06/25	1.52MB	Share
MSB	Mesoblast Maintains Momentum with FDA		12/06/25	188.95KB	Share
MSB	Becoming a substantial holder		06/06/25	443.55KB	Share
MSB	Becoming a substantial holder		05/06/25	2.02MB	Share
MSB	Becoming a substantial holder		03/06/25	1006.62KB	Share
MSB	Ceasing to be a substantial holder		03/06/25	1.37MB	Share
MSB	FDA Provides Ryoncil 7 Years Orphan-Drug Exclusive Approval	PRICE SENSITIVE	15/05/25	173.92KB	Share
MSB	Becoming a substantial holder		14/05/25	1.85MB	Share
MSB	Ceasing to be a substantial holder		09/05/25	1.27MB	Share
MSB	Becoming a substantial holder		08/05/25	1.97MB	Share
MSB	Ceasing to be a substantial holder		07/05/25	241.08KB	Share
MSB	Becoming a substantial holder		02/05/25	328.2KB	Share
MSB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/25	440.59KB	Share
MSB	Initial Director's Interest Notice		29/04/25	230.8KB	Share
MSB	Director Appointment		29/04/25	182.59KB	Share
MSB	Appendix 3Y for Gregory George		24/04/25	256.27KB	Share
MSB	Mesoblast Extends Ryoncil Payer Coverage To 104M US Lives		17/04/25	184.56KB	Share
MSB	Notification of cessation of securities - MSB		14/04/25	12.8KB	Share
MSB	Notification regarding unquoted securities - MSB		14/04/25	14.47KB	Share
MSB	Application for quotation of securities - MSB		14/04/25	17.78KB	Share
MSB	Notification regarding unquoted securities - MSB		14/04/25	15.94KB	Share
MSB	Appendix 3Y - Silviu Itescu, Eric Rose and Philip Krause		08/04/25	284.42KB	Share
MSB	Notification regarding unquoted securities - MSB		08/04/25	16.66KB	Share
MSB	Mesoblast Cell Therapy Products Not Subject to U.S. Tariffs	PRICE SENSITIVE	04/04/25	185.24KB	Share
MSB	Meeting Requested with FDA on Revascor Accelerated Approval		03/04/25	184.42KB	Share
MSB	First Children To Begin Treatment, Medicaid Covers Ryoncil	PRICE SENSITIVE	31/03/25	186.79KB	Share
MSB	Ryoncil Is Now Available For Purchase In The United States	PRICE SENSITIVE	27/03/25	188.31KB	Share
MSB	Ryoncil Published in All Four Major Drug Pricing Compendia		14/03/25	184.26KB	Share
MSB	CEO Presentation at ISCT North America		13/03/25	1.28MB	Share
MSB	Appendix 3Y for Gregory George		13/03/25	257.13KB	Share
MSB	CEO to Deliver Featured Presentation at ISCT North America		12/03/25	196.63KB	Share
MSB	Appendix 3Y and replacement Appendix 3X for Gregory George		07/03/25	415.95KB	Share
MSB	Appendix 3Y for Jane Bell		07/03/25	231.89KB	Share
MSB	Notification regarding unquoted securities - MSB		07/03/25	15.59KB	Share
MSB	Appendix 3Y for Eric Rose		07/03/25	272.69KB	Share
MSB	Mesoblast Added to S&P ASX200 Index		06/03/25	185.74KB	Share
MSB	ZSP: Arcadium Lithium PLC to be removed from the S&P/ASX 200	PRICE SENSITIVE	28/02/25	137.56KB	Share
MSB	Ryoncil Pricing Set and Available This Quarter	PRICE SENSITIVE	27/02/25	395.42KB	Share
MSB	Corporate Presentation and Half Year Financial Results	PRICE SENSITIVE	27/02/25	2.07MB	Share
MSB	Half Year Report and Accounts (including Appendix 4D)	PRICE SENSITIVE	27/02/25	1.77MB	Share
MSB	Mesoblast 2025 Half Year Financial Results Webcast		26/02/25	196.01KB	Share
MSB	Initial Director's Interest Notice		24/02/25	278.67KB	Share
MSB	Director Appointment		24/02/25	183.81KB	Share
MSB	Ryoncil Highlighted at Tandem Transplantation Meetings		14/02/25	270.03KB	Share
MSB	Change in substantial holding		07/02/25	211.96KB	Share
MSB	Ryoncil Commercial Launch Update and Product Pipeline	PRICE SENSITIVE	31/01/25	245.71KB	Share
MSB	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/25	427.9KB	Share
MSB	Cleansing Notice		24/01/25	231.28KB	Share
MSB	Application for quotation of securities - MSB		24/01/25	15.5KB	Share
MSB	Cleansing Notice		22/01/25	212.29KB	Share
MSB	Application for quotation of securities - MSB		22/01/25	15.66KB	Share
MSB	Ceasing to be a substantial holder		22/01/25	888.85KB	Share
MSB	Appendix 3Y for Eric Rose		21/01/25	238.03KB	Share
MSB	Cleansing Notice		20/01/25	211.95KB	Share
MSB	Application for quotation of securities - MSB		17/01/25	14.26KB	Share
MSB	Ceasing to be a substantial holder		16/01/25	558.83KB	Share
MSB	App 3Ys S Itescu J Bell W Burns P Facchina E Rose P Krause		16/01/25	386.75KB	Share
MSB	Notification regarding unquoted securities - MSB		16/01/25	22.99KB	Share
MSB	Notification of cessation of securities - MSB		15/01/25	13.35KB	Share
MSB	Notification regarding unquoted securities - MSB		15/01/25	15.63KB	Share
MSB	Notification regarding unquoted securities - MSB		15/01/25	16KB	Share
MSB	Notification regarding unquoted securities - MSB		15/01/25	14.43KB	Share
MSB	Application for quotation of securities - MSB		15/01/25	17.79KB	Share
MSB	Proposed issue of securities - MSB		14/01/25	14.85KB	Share
MSB	MESOBLAST RAISES NEW CAPITAL FOR RYONCIL COMMERCIAL LAUNCH	PRICE SENSITIVE	14/01/25	225.74KB	Share
MSB	Application for quotation of securities - MSB		10/01/25	15.77KB	Share
MSB	Application for quotation of securities - MSB		10/01/25	15.58KB	Share
MSB	Trading Halt	PRICE SENSITIVE	10/01/25	217.26KB	Share
MSB	Pause in Trading	PRICE SENSITIVE	10/01/25	114.73KB	Share
MSB	Change in substantial holding		10/01/25	1.48MB	Share
MSB	Becoming a substantial holder		09/01/25	1.05MB	Share
MSB	Proposed issue of securities - MSB		06/01/25	15.33KB	Share
MSB	Ceasing to be a substantial holder		06/01/25	776.81KB	Share
MSB	Becoming a substantial holder		27/12/24	1.89MB	Share
MSB	Becoming a substantial holder		24/12/24	1.22MB	Share

MSB Proposed issue of securities - MSB
04/09/25		16.86KB	Share
MSB Mesoblast Option to Issue up to US$50m Convertible Notes
04/09/25	PRICE SENSITIVE	158.61KB	Share
MSB Becoming a substantial holder
29/08/25		469.8KB	Share
MSB MSB Annual Financial Results and Operational Update
29/08/25	PRICE SENSITIVE	411.86KB	Share
MSB Annual Financial Results Presentation
29/08/25	PRICE SENSITIVE	2.08MB	Share
MSB Preliminary Final Report including Appendix 4E
29/08/25	PRICE SENSITIVE	2.69MB	Share
MSB Mesoblast 2025 Full Year Financial Results Webcast
27/08/25		190.38KB	Share
MSB Ceasing to be a substantial holder
25/08/25		584.98KB	Share
MSB Becoming a substantial holder
29/07/25		806.3KB	Share
MSB Ceasing to be a substantial holder
25/07/25		559.18KB	Share
MSB Ceasing to be a substantial holder
25/07/25		1.58MB	Share
MSB Becoming a substantial holder
23/07/25		2.04MB	Share
MSB Ceasing to be a substantial holder
21/07/25		1.51MB	Share
MSB Quarterly Activities/Appendix 4C Cash Flow Report
18/07/25	PRICE SENSITIVE	455.43KB	Share
MSB Becoming a substantial holder
18/07/25		2.32MB	Share
MSB Notification of cessation of securities - MSB
14/07/25		12.81KB	Share
MSB Notification regarding unquoted securities - MSB
14/07/25		14.47KB	Share
MSB Application for quotation of securities - MSB
14/07/25		17.77KB	Share
MSB Notification regarding unquoted securities - MSB
14/07/25		15.93KB	Share
MSB Ceasing to be a substantial holder
08/07/25		1.29MB	Share
MSB Becoming a substantial holder
07/07/25		2.06MB	Share
MSB Mesoblast and FDA Align on Key Items for Revascor BLA
01/07/25		184.33KB	Share
MSB Ceasing to be a substantial holder
26/06/25		1.16MB	Share
MSB Ceasing to be a substantial holder
18/06/25		243.32KB	Share
MSB Becoming a substantial holder
17/06/25		1.88MB	Share
MSB Ceasing to be a substantial holder
16/06/25		1.52MB	Share
MSB Mesoblast Maintains Momentum with FDA
12/06/25		188.95KB	Share
MSB Becoming a substantial holder
06/06/25		443.55KB	Share
MSB Becoming a substantial holder
05/06/25		2.02MB	Share
MSB Becoming a substantial holder
03/06/25		1006.62KB	Share
MSB Ceasing to be a substantial holder
03/06/25		1.37MB	Share
MSB FDA Provides Ryoncil 7 Years Orphan-Drug Exclusive Approval
15/05/25	PRICE SENSITIVE	173.92KB	Share
MSB Becoming a substantial holder
14/05/25		1.85MB	Share
MSB Ceasing to be a substantial holder
09/05/25		1.27MB	Share
MSB Becoming a substantial holder
08/05/25		1.97MB	Share
MSB Ceasing to be a substantial holder
07/05/25		241.08KB	Share
MSB Becoming a substantial holder
02/05/25		328.2KB	Share
MSB Quarterly Activities/Appendix 4C Cash Flow Report
30/04/25	PRICE SENSITIVE	440.59KB	Share
MSB Initial Director's Interest Notice
29/04/25		230.8KB	Share
MSB Director Appointment
29/04/25		182.59KB	Share
MSB Appendix 3Y for Gregory George
24/04/25		256.27KB	Share
MSB Mesoblast Extends Ryoncil Payer Coverage To 104M US Lives
17/04/25		184.56KB	Share
MSB Notification of cessation of securities - MSB
14/04/25		12.8KB	Share
MSB Notification regarding unquoted securities - MSB
14/04/25		14.47KB	Share
MSB Application for quotation of securities - MSB
14/04/25		17.78KB	Share
MSB Notification regarding unquoted securities - MSB
14/04/25		15.94KB	Share
MSB Appendix 3Y - Silviu Itescu, Eric Rose and Philip Krause
08/04/25		284.42KB	Share
MSB Notification regarding unquoted securities - MSB
08/04/25		16.66KB	Share
MSB Mesoblast Cell Therapy Products Not Subject to U.S. Tariffs
04/04/25	PRICE SENSITIVE	185.24KB	Share
MSB Meeting Requested with FDA on Revascor Accelerated Approval
03/04/25		184.42KB	Share
MSB First Children To Begin Treatment, Medicaid Covers Ryoncil
31/03/25	PRICE SENSITIVE	186.79KB	Share
MSB Ryoncil Is Now Available For Purchase In The United States
27/03/25	PRICE SENSITIVE	188.31KB	Share
MSB Ryoncil Published in All Four Major Drug Pricing Compendia
14/03/25		184.26KB	Share
MSB CEO Presentation at ISCT North America
13/03/25		1.28MB	Share
MSB Appendix 3Y for Gregory George
13/03/25		257.13KB	Share
MSB CEO to Deliver Featured Presentation at ISCT North America
12/03/25		196.63KB	Share
MSB Appendix 3Y and replacement Appendix 3X for Gregory George
07/03/25		415.95KB	Share
MSB Appendix 3Y for Jane Bell
07/03/25		231.89KB	Share
MSB Notification regarding unquoted securities - MSB
07/03/25		15.59KB	Share
MSB Appendix 3Y for Eric Rose
07/03/25		272.69KB	Share
MSB Mesoblast Added to S&P ASX200 Index
06/03/25		185.74KB	Share
MSB ZSP: Arcadium Lithium PLC to be removed from the S&P/ASX 200
28/02/25	PRICE SENSITIVE	137.56KB	Share
MSB Ryoncil Pricing Set and Available This Quarter
27/02/25	PRICE SENSITIVE	395.42KB	Share
MSB Corporate Presentation and Half Year Financial Results
27/02/25	PRICE SENSITIVE	2.07MB	Share
MSB Half Year Report and Accounts (including Appendix 4D)
27/02/25	PRICE SENSITIVE	1.77MB	Share
MSB Mesoblast 2025 Half Year Financial Results Webcast
26/02/25		196.01KB	Share
MSB Initial Director's Interest Notice
24/02/25		278.67KB	Share
MSB Director Appointment
24/02/25		183.81KB	Share
MSB Ryoncil Highlighted at Tandem Transplantation Meetings
14/02/25		270.03KB	Share
MSB Change in substantial holding
07/02/25		211.96KB	Share
MSB Ryoncil Commercial Launch Update and Product Pipeline
31/01/25	PRICE SENSITIVE	245.71KB	Share
MSB Quarterly Activities/Appendix 4C Cash Flow Report
31/01/25	PRICE SENSITIVE	427.9KB	Share
MSB Cleansing Notice
24/01/25		231.28KB	Share
MSB Application for quotation of securities - MSB
24/01/25		15.5KB	Share
MSB Cleansing Notice
22/01/25		212.29KB	Share
MSB Application for quotation of securities - MSB
22/01/25		15.66KB	Share
MSB Ceasing to be a substantial holder
22/01/25		888.85KB	Share
MSB Appendix 3Y for Eric Rose
21/01/25		238.03KB	Share
MSB Cleansing Notice
20/01/25		211.95KB	Share
MSB Application for quotation of securities - MSB
17/01/25		14.26KB	Share
MSB Ceasing to be a substantial holder
16/01/25		558.83KB	Share
MSB App 3Ys S Itescu J Bell W Burns P Facchina E Rose P Krause
16/01/25		386.75KB	Share
MSB Notification regarding unquoted securities - MSB
16/01/25		22.99KB	Share
MSB Notification of cessation of securities - MSB
15/01/25		13.35KB	Share
MSB Notification regarding unquoted securities - MSB
15/01/25		15.63KB	Share
MSB Notification regarding unquoted securities - MSB
15/01/25		16KB	Share
MSB Notification regarding unquoted securities - MSB
15/01/25		14.43KB	Share
MSB Application for quotation of securities - MSB
15/01/25		17.79KB	Share
MSB Proposed issue of securities - MSB
14/01/25		14.85KB	Share
MSB MESOBLAST RAISES NEW CAPITAL FOR RYONCIL COMMERCIAL LAUNCH
14/01/25	PRICE SENSITIVE	225.74KB	Share
MSB Application for quotation of securities - MSB
10/01/25		15.77KB	Share
MSB Application for quotation of securities - MSB
10/01/25		15.58KB	Share
MSB Trading Halt
10/01/25	PRICE SENSITIVE	217.26KB	Share
MSB Pause in Trading
10/01/25	PRICE SENSITIVE	114.73KB	Share
MSB Change in substantial holding
10/01/25		1.48MB	Share
MSB Becoming a substantial holder
09/01/25		1.05MB	Share
MSB Proposed issue of securities - MSB
06/01/25		15.33KB	Share
MSB Ceasing to be a substantial holder
06/01/25		776.81KB	Share
MSB Becoming a substantial holder
27/12/24		1.89MB	Share
MSB Becoming a substantial holder
24/12/24		1.22MB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.12		Change 0.130(6.53%)		Mkt cap ! $2.713B

Open	High	Low	Value	Volume
$2.02	$2.13	$2.02	$11.00M	5.286M

Buyers (Bids)

No.	Vol.	Price($)
4	54317	$2.11

Sellers (Offers)

Price($)	Vol.	No.
$2.12	20700	2

View Market Depth

No.	Vol.	Price($)
2	10000	2.110
4	17470	2.100
2	14569	2.090
2	24500	2.080
1	500	2.070

Price($)	Vol.	No.
2.120	20700	2
2.130	48535	2
2.140	19044	4
2.150	27250	7
2.170	11000	2

Last trade - 16.20pm 05/09/2025 (20 minute delay)

MSB (ASX) Chart

MESOBLAST LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories